Viewing Study NCT01012102


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-01-06 @ 11:25 PM
Study NCT ID: NCT01012102
Status: COMPLETED
Last Update Posted: 2014-02-20
First Post: 2009-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module